19 and older, any sex, with Sexual Assault Precursor Behavior. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants Who Reported Always Intervening Behavior at 6 MonthsPrimary· at baseline and up to 6 months
Self-reported survey items measuring actual behavior (action taken) in response to observation of sexual aggression in the bar environment will be analyzed to identify significant differences post-intervention.
Group
Value
95% CI
Control Staff
207
Intervention Staff
239
Did Not Offer Promotions Aimed at Attracting Female Patrons Post-interventionPrimary· at baseline and up to 3 months
Self-reported survey items completed by bar owners/managers regarding promotions aimed at attracting female patrons
Group
Value
95% CI
Control Managers
13
Intervention Managers
15
Sponsor's own description
The goal is to evaluate at three sites the implementation of the Safer Bars sexual assault prevention program.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mary Koss
Last refreshed: 27 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04141839.